Glenmark Pharmaceuticals Limited
Stock Forecast, Prediction & Price Target
Glenmark Pharmaceuticals Limited Financial Estimates
Glenmark Pharmaceuticals Limited Revenue Estimates
Glenmark Pharmaceuticals Limited EBITDA Estimates
Glenmark Pharmaceuticals Limited Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 3/31/2021 | 3/31/2022 | 3/31/2024 | 3/31/2026 | 3/31/2027 | ||
Revenue
% change YoY
| ₹108.06B N/A | ₹121.74B 12.66% | ₹118.13B -2.96% | Avg: ₹153.62B Low: ₹153.62B High: ₹153.62B avg. 30.05% | Avg: ₹174.74B Low: ₹174.74B High: ₹174.74B avg. 13.74% | ||
Net Income
% change YoY
| ₹9.70B N/A | ₹9.41B -2.92% | ₹-15.01B -259.46% | Avg: ₹16.31B Low: ₹14.22B High: ₹18.93B avg. 208.64% | Avg: ₹21.35B Low: ₹21.30B High: ₹22.16B avg. 30.87% | ||
EBITDA
% change YoY
| ₹21.79B N/A | ₹24.93B 14.42% | ₹11.34B -54.50% | Avg: ₹27.23B Low: ₹27.23B High: ₹27.23B avg. 140.04% | Avg: ₹30.97B Low: ₹30.97B High: ₹30.97B avg. 13.74% | ||
EPS
% change YoY
| $34.38 N/A | $33.37 -2.93% | -$53.22 -259.48% | Avg: $58.53 Low: $50.4 High: $67.11 avg. 209.98% | Avg: $76.65 Low: $75.5 High: $78.56 avg. 30.95% | ||
Operating Expenses
% change YoY
| ₹53.46B N/A | ₹58.74B 9.88% | ₹46.95B -20.07% | Avg: ₹22.31B Low: ₹22.31B High: ₹22.31B avg. -52.46% | Avg: ₹25.38B Low: ₹25.38B High: ₹25.38B avg. 13.74% | ||
FAQ
What is Glenmark Pharmaceuticals Limited stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 119.75% in 2026-2027.
We have gathered data from 11 analysts. Their low estimate is 14.22B, average is 16.31B and high is 18.93B.
What is Glenmark Pharmaceuticals Limited stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 21.89% in 2026-2027.
We have gathered data from 13 analysts. Their low revenue estimate is ₹153.62B, average is ₹153.62B and high is ₹153.62B.
What is Glenmark Pharmaceuticals Limited stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 120.47% in 2026-2027.
We have gathered data from 11 analysts. Their low earnings per share estimate is $50.4, average is $58.53 and high is ₹67.11.